Related Experiment Videos

Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis

Osamu Oikawa1, Terumi Higuchi2, Toshio Yamazaki1

  • 1Division of Nephrology and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.

Clinical and Experimental Nephrology
|December 19, 2007
PubMed

Insights

Serum fetuin-A levels are lower in hemodialysis patients and correlate with poorer health markers. Low fetuin-A may predict malnutrition, inflammation, and cardiac issues in these patients.

Area of Science:

  • Nephrology
  • Biochemistry
  • Cardiovascular Medicine

Background:

  • Atherosclerosis complications in dialysis patients are a growing concern.
  • Fetuin-A, a glycoprotein inhibiting vascular calcification, is linked to inflammation and outcomes in dialysis patients.
  • This study investigates the relationship between serum fetuin-A and biochemical markers in hemodialysis patients.

Purpose of the Study:

  • To examine the association between serum fetuin-A concentrations and various biochemical parameters in patients undergoing hemodialysis.
  • To determine if fetuin-A levels can serve as a predictor for specific health conditions in this patient group.

Main Methods:

  • Serum fetuin-A was measured using enzyme-linked immunosorbent assay in 40 hemodialysis patients and 20 controls.
  • Key biochemical parameters including albumin, calcium, phosphate, parathyroid hormone, lipids, BNP, hsCRP, and hemoglobin were analyzed.
  • Regression analysis was performed on variables such as dialysis duration, BMI, and mean arterial pressure.

Main Results:

  • Hemodialysis patients exhibited significantly lower serum fetuin-A levels compared to healthy controls (331 ± 55 vs. 361 ± 55 μg/ml, P < 0.05).
  • Serum fetuin-A showed a negative correlation with dialysis duration (r = -0.37), brain natriuretic peptide (BNP) (r = -0.37), and highly sensitive C-reactive protein (hsCRP) (r = -0.40).
  • A positive association was observed between serum fetuin-A and serum albumin (r = 0.31).

Conclusions:

  • Low serum fetuin-A levels in hemodialysis patients are associated with increased inflammation and malnutrition.
  • Reduced fetuin-A may serve as a predictive marker for cardiac failure due to increased ventricular load in patients on hemodialysis.
  • These findings highlight fetuin-A's potential role in assessing the health status and predicting complications in dialysis patients.
Abstract

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...